Lexaria Bioscience (LEXX) Selling, General & Administrative (2017 - 2026)
Lexaria Bioscience (LEXX) recorded Selling, General & Administrative of $1.02 million in fiscal Q3 2026 (quarter ended May 31, 2026), down 15.2% from $1.21 million a year earlier but up 2.7% from the prior quarter.
Lexaria Bioscience (LEXX) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a TTM basis, Lexaria Bioscience's Selling, General & Administrative came in at $3.9 million as of May 31, 2026, down 16.7% year-over-year; for FY2025 (ended Aug 31, 2025), it was $4.35 million, up 12.8% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- Across earlier fiscal years, Selling, General & Administrative came in at $3.85 million in FY2024 (+25.8%), $3.06 million in FY2023 (-38.3%), $4.96 million in FY2022 (-0.2%) and $4.97 million in FY2021 (+25.0%).
- Quarterly Selling, General & Administrative has ranged from $462,260 in fiscal Q4 2022 to $1.75 million in fiscal Q3 2022 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for five consecutive quarters, with growth averaging 23.3% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 118.4% in fiscal Q2 2025, against a decline of 76.9% in fiscal Q4 2021 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $996,515 (Q2 2026), $902,291 (Q1 2026) and $980,477 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | 1.02 Mn |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1.02 Mn |
| Feb 28, 2026 | 996,515.00 |
| Nov 30, 2025 | 902,291.00 |
| Aug 31, 2025 | 980,477.00 |
| May 31, 2025 | 1.21 Mn |
| Feb 28, 2025 | 1.24 Mn |
| Nov 30, 2024 | 918,690.00 |
| Aug 31, 2024 | 1.32 Mn |
| May 31, 2024 | 1.25 Mn |
| Feb 29, 2024 | 567,226.00 |
| Nov 30, 2023 | 711,107.00 |
| Aug 31, 2023 | 644,448.00 |
| May 31, 2023 | 825,177.00 |
| Feb 28, 2023 | 644,514.00 |
| Nov 30, 2022 | 947,870.00 |
| Aug 31, 2022 | 462,260.00 |
| May 31, 2022 | 1.75 Mn |
| Feb 28, 2022 | 1.20 Mn |
| Nov 30, 2021 | 1.55 Mn |
| Aug 31, 2021 | 873,584.00 |
Lexaria Bioscience Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();